Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers

Simple item page
dc.contributor.authorGokalp F.
dc.contributor.authorCelik S.
dc.contributor.authorSozen T.S.
dc.contributor.authorOzen A.H.
dc.contributor.authorAslan G.
dc.contributor.authorIzol V.
dc.contributor.authorBaltaci S.
dc.contributor.authorMuezzinoglu T.
dc.contributor.authorAkdogan B.
dc.contributor.authorSuer E.
dc.contributor.authorTinay I.
dc.date.accessioned2025-04-10T11:04:04Z
dc.date.available2025-04-10T11:04:04Z
dc.date.issued2023
dc.description.abstractPurpose: We aimed to compare oncological outcomes in the two rare subtypes, unclassified renal cell cancer (unRCC) and translocation RCC (tRCC), vs clear cell RCC (ccRCC).Materials and Methods: Between 2004 and 2019, from Turkish Urooncology Society Database, we identified 2324 patients for histological subtypes including 80 unRCC (3.4%), 19 tRCC (0.8%) and 2225 ccRCC (95.8%).Results: The overall (15.8%) and cancer-specific mortalities (11.1%) were found to be higher in tRCC group and the recurrence free mortality (13.8%) was found to be higher in unRCC group. Larger pathological tumor size (p = 0.012) and advanced pathological T stage (p = 0.042) were independent predictive factors on overall mortality in patients with unRCC tumors.Conclusion: The oncological outcomes of the unRCC and tRCC are worse than ccRCC and pathological tumor size and pathological stage are predictive factors for mortality in the unRCC © 2023, Urology Journal.All Rights Reserved.
dc.identifier.DOI-ID10.22037/uj.v19i.7091
dc.identifier.urihttp://hdl.handle.net/20.500.14701/45140
dc.publisherUrology and Nephrology Research Centre
dc.titleOncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers
dc.typeArticle

Files

Collections

Scopus Koleksiyonu